Toronto, ON, April 9, 2025 – The Canadian Epilepsy Alliance (CEA) is celebrating a major step forward for people living with epilepsy. An agreement has been reached between the pan-Canadian Pharmaceutical Alliance (pCPA) and Paladin Pharma for Xcopri (cenobamate), a new treatment that offers hope to patients who have not responded to other medications. Now, it’s up to the provinces to take action and make sure those who need it can access it without financial barriers.
“For far too long, patients and families have been waiting for access to Xcopri,” said Laura Dickson, President of the CEA. “This medication has been approved in Canada for nearly 2 years, and people with epilepsy should not have to keep fighting just to get the treatment they need. We urge provinces to move quickly so that those struggling with uncontrolled seizures can finally get relief.”
Uncontrolled seizures can have a devastating impact on every part of a person’s life, affecting their ability to work, go to school, and even perform daily activities safely. Many people living with epilepsy have already faced difficulties due to recent medication shortages, making access to effective treatment even more urgent.
Patients and caregivers across the country have been vocal about their need for Xcopri, sharing stories of the toll that uncontrolled seizures take on their health and well-being. “We hear from patients all the time who have exhausted all other treatment options,” said Laura Dickson, President of the CEA. “They deserve better. They deserve access to medications that could change their lives.”
CEA is calling on provincial governments to listen to the voices of the epilepsy community and ensure that Xcopri is made available as soon as possible. “This isn’t just about drug listings—it’s about people. It’s about giving Canadians living with epilepsy a chance at a better life.”
CEA remains committed to advocating for equitable access to treatments that improve the lives of those affected by epilepsy. We encourage patients, caregivers, and healthcare professionals to continue raising their voices and advocating for timely access to this essential therapy.
For more information or to schedule interviews, please contact: Trevor Gordon communications@canadianepilepsyalliance.org
About the Canadian Epilepsy Alliance
The Canadian Epilepsy Alliance (CEA) is a Canada-wide network of 26 community-based agencies promoting independence and quality of life for people affected by epilepsy. Member Associations provide a range of support services, information, advocacy and public awareness from coast-to-coast. This includes counselling, education, advocacy, public awareness, employment assistance, children’s programs and support groups. CEA’s vision is to ensure every person living with epilepsy has the opportunity to achieve his/her fullest potential and participate in and contribute to all aspects of life.
